Last reviewed 2026-04-20 · How we verify

Iron-59 Citrate (ferric (59Fe) citrate)

Iron-59 Citrate (generic name: ferric (59Fe) citrate) is a ferric (59Fe) citrate drug. It is currently in unknown development.

Iron-59 Citrate works by providing the body with iron, a crucial element for healthy red blood cells.

Iron-59 Citrate, also known as ferric (59Fe) citrate, is a small molecule drug in the ferric (59Fe) citrate class. Its exact target and indications are unknown, and its commercial status, including FDA approval and patent status, is also unclear. As a ferric (59Fe) citrate, it is likely used to treat iron deficiency or anemia, but more information is needed to confirm its specific use. The drug's half-life, bioavailability, and generic manufacturers are also unknown. Further research is necessary to fully understand its properties and applications.

At a glance

Mechanism of action

Think of iron like a key that helps your body make healthy red blood cells. When you're low on iron, your body can't make enough red blood cells, leading to fatigue, weakness, and other symptoms. Iron-59 Citrate helps fill the iron gap, allowing your body to produce healthy red blood cells and alleviate these symptoms.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Iron-59 Citrate CI brief — competitive landscape report
• Iron-59 Citrate updates RSS · CI watch RSS
• portfolio CI

Frequently asked questions about Iron-59 Citrate

Related

• Drug class: All ferric (59Fe) citrate drugs
• Manufacturer: — full pipeline
• Therapeutic area: All drugs in Hematology

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing